Biotech's 2026 Comeback: XBI Index Surges 75% from April Lows as M&A Wave Approaches
The biotech sector has staged a remarkable recovery from its April 2025 bottom, with analysts predicting 20+ billion-dollar acquisitions in 2026 as pharma giants race to fill patent gaps.